Stock 301301 YILI CHUANNING BIOTECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Yili Chuanning Biotechnology Co.,Ltd.

Equities

301301

CNE100005WX0

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 06/06/2024 BST 		5-day change 1st Jan Change
13.09 CNY -1.28% Intraday chart for Yili Chuanning Biotechnology Co.,Ltd. -1.58% +55.83%
04-21 Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Yili Chuanning Biotechnology Co.,Ltd. Approves Cash Dividend for the Year 2023
CI
Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Yili Chuanning Biotechnology Signs Cooperation Deal With Jinhui Technology
MT
Certain A Shares of Yili Chuanning Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 27-DEC-2023.
CI
Yili Chuanning Biotechnology Co.,Ltd.(SZSE:301301) added to Shenzhen Stock Exchange Component Index
CI
Yili Chuanning Biotechnology Co.,Ltd.(SZSE:301301) added to Shenzhen Stock Exchange Component A Share Index
CI
Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Yili Chuannig Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Yili Chuannig Biotechnology Co., Ltd.(XSEC:301301) added to S&P Global BMI Index
CI
Yili Chuannig Biotechnology Co., Ltd. Implements Final Cash Dividend on A Shares for 2022, Payable on 29 May 2023
CI
Yili Chuannig Biotechnology Co., Ltd. Approves Directorate Appointments
CI
Yili Chuannig Biotechnology Co., Ltd. Approves Final Cash Dividend for 2022
CI
Yili Chuannig Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Yili Chuannig Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2022
CI
Shanghai Ruikang Biotechnology R&D Co., Ltd. announced that it expects to receive CNY 100 million in funding from Yili Chuannig Biotechnology Co., Ltd.
CI
Yili Chuannig Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Yili Chuannig Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301301 Stock
  4. News Yili Chuanning Biotechnology Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW